new post
StocksRunner logo
mail
search
 
menu
 
Arcellx Inc.
$114.29
-0.06%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

ACLX Stock Analysis & IQ Rating | Arcellx Inc.

 
 

ACLX

 

Arcellx Inc.

$114.29

 
-$0.07 | -0.06%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$114.8
 
 
MKT CAP
$6.68B
 
52W Low
$47.86
 
 
VOL
$1.46M
 
P/E Ratio
N/A
 
 
AVG VOL
$3.32M
 
RSI
83.57
 
 
TREND
Uptrend
 
 
 

ACLX Stock IQ

 
lock  Login to see Arcellx Inc. (ACLX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

ACLX Target Price

 
 
 

Strengths

 
 

ACLX Rewards

 Upgraded on attractively valued

ACLX Rewards

 Earnings are forecast to grow

 
 

ACLX Price Performance

 
 

$68.5   (+66.85%)

$66.33   (+72.31%)

$87   (+31.37%)

$67.96   (+68.17%)

 
 
1year
6month
3month
1month

ACLX Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

Rating

×

Rating

ACLX Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

Future

×

Future

ACLX Future Sentiment Earnings are forecast to grow
ACLX Analysts Opinion

ACLX Analysts opinion is negative and it remained unchanged from the past 3 months

ACLX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

50%
Consensus Rating
100%
Buy
Opinion
100%
Trend
Score
0%
Potential
Score
ACLX Street Sentiment

ACLX Street Sentiment is bullish and have positive views on the near-term outlook

ACLX Risk Level

ACLX has Low risk level

ACLX Risk Level
Low
LOW
HIGH

ACLX Performance Sentiment

Sentiments overview associated with events and the stock performance

50%
Positive
3 out of 6
events present
33%
Negative
2 out of 6
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$113.75
Resistance Price
$114.50
Current Price Range
$114.29
$113.75
$114.50
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
6
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Jan 30, 2026

 

Initiate

 

Buy

 

UBS

 

Dec 23, 2025

 

Initiate

 

Overweight

 

Wells Fargo

 

Dec 08, 2025

 

Reiterate

 

Buy

 

Needham

 

Nov 30, 2025

 

Reiterate

 

Buy

 

Morgan Stanley

 

Nov 04, 2025

 

Reiterate

 

Buy

 

Canaccord Genuity

 
 
 
Runners Also Watch
Close Price
Change
 

GILD

Gilead Sciences

145.21

-0.54%

 
 
 
ACLX Latest Analysis +
 
 
FAQ About ACLX Stock Insights
 

What is ACLX current stock price?

What are ACLX stock strengths?

What is ACLX Risk Level?

What is ACLX market cap and volume?

What is ACLX current Stock IQ?

Should I buy ACLX stock right now?

Is ACLX a Strong Buy right now?

What does a 'Strong Buy' rating mean for ACLX?

What does a 'Strong Sell' rating mean for ACLX?

What factors influence ACLX's Stock IQ?

 
 
StocksRunner

Explore our ACLX Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored ACLX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ACLX Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

ACLX

 

Arcellx Inc.

 
Set Alerts
 
 

Current Price

 

$114.29

 
-$0.07 | -0.06%
 
 
52W High
$114.8
 
 
MKT CAP
$6.68B
 
52W Low
$47.86
 
 
VOL
$1.46M
 
P/E Ratio
N/A
 
 
AVG VOL
$3.32M
 
RSI
83.57
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 

Runners Also Watch

 
 
 
Symbol
Close
Change
 

GILD

Gilead Sciences

145.21

-0.54%

 
 
 
 
 
user
 
 
 
 

ACLX Price Performance

 
 

$68.5   (+66.85%)

$66.33   (+72.31%)

$87   (+31.37%)

$67.96   (+68.17%)

 
 
1year
6month
3month
1month
 

ACLX Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

Rating

×

Rating

ACLX Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

Future

×

Future

ACLX Future Sentiment Earnings are forecast to grow
ACLX Analysts Opinion

ACLX Analysts opinion is negative and it remained unchanged from the past 3 months

ACLX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

50%
Consensus Rating
100%
Buy
Opinion
100%
Trend
Score
0%
Potential
Score
ACLX Street Sentiment

ACLX Street Sentiment is bullish and have positive views on the near-term outlook

ACLX Risk Level

ACLX has Low risk level

ACLX Risk Level
Low
LOW
HIGH
ACLX Performance Sentiment
Sentiments overview associated with events and the stock performance.
50%
Positive
3 out of 6
events present
33%
Negative
2 out of 6
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$113.75
Resistance Price
$114.50
Current Price Range
$114.29
$113.75
$114.50
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
6
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Jan 30, 2026
Initiate
Buy
UBS
Dec 23, 2025
Initiate
Overweight
Wells Fargo
Dec 08, 2025
Reiterate
Buy
Needham
Nov 30, 2025
Reiterate
Buy
Morgan Stanley
Nov 04, 2025
Reiterate
Buy
Canaccord Genuity
 
 
 
 

ACLX Stock IQ

 
 
 
lock  Login to unlock Arcellx Inc. (ACLX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

ACLX Rewards

 Upgraded on attractively valued

ACLX Rewards

 Earnings are forecast to grow

 
 
 

ACLX Latest Analysis

 
 
 

Gilead Snaps Up Arcellx For $115 Per Share — A $7.8 Billion Bet On Cancer Therapy. Arcellx Inc. (NASDAQ:ACLX) shares rose on Wednesday after Gilead Sciences Inc. (NASDAQ:GILD) agreed to acquire the company for $7.8 billion or $115 per share in cash.While Gilead'.s acquisition values Arcellx at an implied $7.8 billion in equity it includes a $5-per-share contingent value right. The deal strengthens Gilead'.s oncology portfolio centered on anito-cel a CAR T-cell therapy for multiple myelom

 

Wed Feb 25, 2026

$113.76 | +0.01%
 
Activity

Arcellx Reaches Analyst Target Price. In recent trading shares of Arcellx Inc (Symbol: ACLX) have crossed above the average analyst 12-month target price of $111.94 changing hands for $113.75/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade on valuat

 

Tue Feb 24, 2026

$113.75 | 0.00%
 
Potential

Noteworthy Monday Option Activity: ACLX VRSK DOCN. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Arcellx Inc (Symbol: ACLX) where a total volume of 4640 contracts has been traded thus far today a contract volume which is representative of approximately 46

 

Mon Feb 23, 2026

$113.75 | +77.43%
 
Momentum

Shareholder Alert: The Ademi Firm investigates whether Arcellx Inc. is obtaining a Fair Price for its Public Shareholders. MILWAUKEE Feb. 23 2026 /PRNewswire/ -- Ademi LLP is investigating Arcellx (NASDAQ: ACLX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Gilead. Click here to learn how to join our investigation and obtain additional...

 

Mon Feb 23, 2026

$113.75 | +77.43%
 
Activity

Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma Drug. On Monday GILD) announced it is acquiring ) to enhance its .Gilead currently owns approximately 11.5% of Arcellx’.s outstanding common stock.Gilead Sciences on Monday agreed to acquire Arcellx for $115 per share in cash along with a contingent value right of $5 per share totaling an implied equity value of $7.8 billion.The acquisition aims to provide Gilead with full control over anitocabtagene autoleucel (anito-cel) a promising for

 

Mon Feb 23, 2026

$113.75 | +77.43%
 
Activity
 
 
 
 
 
StocksRunner

Discover ACLX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ACLX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ACLX Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ACLX Stock trends

ACLX Stock performance

ACLX Stock analysis

ACLX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

ACLX Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing ACLX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing ACLX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.